BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 27093454)

  • 1. A Selected Immunohistochemical Panel Aids in Differential Diagnosis and Prognostic Stratification of Subtypes of High-grade Endometrial Carcinoma: A Clinicopathologic and Immunohistochemical Study at a Single Institution.
    Taskin OÇ; Onder S; Topuz S; Sozen H; Sen F; Ilhan R; Yavuz E
    Appl Immunohistochem Mol Morphol; 2017; 25(10):696-702. PubMed ID: 27093454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical characterization of prototypical endometrial clear cell carcinoma--diagnostic utility of HNF-1β and oestrogen receptor.
    Hoang LN; Han G; McConechy M; Lau S; Chow C; Gilks CB; Huntsman DG; Köbel M; Lee CH
    Histopathology; 2014 Mar; 64(4):585-96. PubMed ID: 24103020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic Association and Prognostic Value of Microcystic, Elongated, and Fragmented (MELF) Pattern in Endometrial Endometrioid Carcinoma.
    Kihara A; Yoshida H; Watanabe R; Takahashi K; Kato T; Ino Y; Kitagawa M; Hiraoka N
    Am J Surg Pathol; 2017 Jul; 41(7):896-905. PubMed ID: 28418994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathologic analysis of matched primary and recurrent endometrial carcinoma.
    Soslow RA; Wethington SL; Cesari M; Chiappetta D; Olvera N; Shia J; Levine DA
    Am J Surg Pathol; 2012 Dec; 36(12):1771-81. PubMed ID: 23154767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclin D1 is significantly associated with stage of tumor and predicts poor survival in endometrial carcinoma patients.
    Khabaz MN; Abdelrahman AS; Butt NS; Al-Maghrabi B; Al-Maghrabi J
    Ann Diagn Pathol; 2017 Oct; 30():47-51. PubMed ID: 28965628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer.
    Amant F; Cadron I; Fuso L; Berteloot P; de Jonge E; Jacomen G; Van Robaeys J; Neven P; Moerman P; Vergote I
    Gynecol Oncol; 2005 Aug; 98(2):274-80. PubMed ID: 15972232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases.
    Yemelyanova A; Ji H; Shih IeM; Wang TL; Wu LS; Ronnett BM
    Am J Surg Pathol; 2009 Oct; 33(10):1504-14. PubMed ID: 19623034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mixed and Ambiguous Endometrial Carcinomas: A Heterogenous Group of Tumors With Different Clinicopathologic and Molecular Genetic Features.
    Espinosa I; D'Angelo E; Palacios J; Prat J
    Am J Surg Pathol; 2016 Jul; 40(7):972-81. PubMed ID: 26975040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Un- and dedifferentiated endometrial carcinoma : A rare entity with a wide range of differential diagnosis].
    Höhn AK; Brambs CE; Opitz S; Erber R; Hartmann A; Horn LC
    Pathologe; 2019 Nov; 40(6):609-618. PubMed ID: 31578630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Updates in diagnostic immunohistochemistry in endometrial carcinoma.
    Chiang S; Soslow RA
    Semin Diagn Pathol; 2014 May; 31(3):205-15. PubMed ID: 24951284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of Androgen Receptor Expression on Endometrial Carcinoma Recurrence and Survival.
    Mahdi Z; Abdulfatah E; Pardeshi V; Hassan O; Schultz D; Morris R; Cote ML; Elshaikh MA; Bandyopadhyay S; Ali-Fehmi R
    Int J Gynecol Pathol; 2017 Sep; 36(5):405-411. PubMed ID: 28277313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Undifferentiated Carcinoma of the Endometrium: An Expanded Immunohistochemical Analysis Including PAX-8 and Basal-Like Carcinoma Surrogate Markers.
    Ramalingam P; Masand RP; Euscher ED; Malpica A
    Int J Gynecol Pathol; 2016 Sep; 35(5):410-8. PubMed ID: 26598976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Undifferentiated endometrial carcinoma arising in the background of high-grade endometrial carcinoma - Expanding the definition of dedifferentiated endometrial carcinoma.
    Busca A; Parra-Herran C; Nofech-Mozes S; Djordjevic B; Ismiil N; Cesari M; Nucci MR; Mirkovic J
    Histopathology; 2020 Nov; 77(5):769-780. PubMed ID: 32557836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular profile of grade 3 endometrioid endometrial carcinoma: is it a type I or type II endometrial carcinoma?
    Alvarez T; Miller E; Duska L; Oliva E
    Am J Surg Pathol; 2012 May; 36(5):753-61. PubMed ID: 22498825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance and diagnostic value of PTEN and p53 expression in endometrial carcinoma. A retrospective clinicopathological and immunohistochemical study.
    Daniilidou K; Frangou-Plemenou M; Grammatikakis J; Grigoriou O; Vitoratos N; Kondi-Pafiti A
    J BUON; 2013; 18(1):195-201. PubMed ID: 23613406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical Detection of Hematopoietic Cell-specific Protein-Tyrosine Phosphatase (Tyrosine Phosphatase SHP-1) in a Series of Endometrioid and Serous Endometrial Carcinoma.
    Giordano G; Campanini N; Goldoni M; Rodolfi AM; Brigati F; Merisio C; Berretta R
    Appl Immunohistochem Mol Morphol; 2018 Aug; 26(7):468-477. PubMed ID: 28187032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serous versus high-grade endometrioid endometrial carcinoma: immunohistochemistry of RFP is not useful for differentiation.
    Ussakli C; Usubutun A; Dincer N; Dolgun A; Bülbül D; Isikdogan Z; Haberal N; Ozen O; Tezel GG
    Pol J Pathol; 2016; 67(3):221-227. PubMed ID: 28155970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poor interobserver reproducibility in the diagnosis of high-grade endometrial carcinoma.
    Gilks CB; Oliva E; Soslow RA
    Am J Surg Pathol; 2013 Jun; 37(6):874-81. PubMed ID: 23629444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical study of endometrial high-grade endometrioid carcinoma with or without a concurrent low-grade component: implications for pathogenetic and survival differences.
    Mao TL; Ayhan A; Kuo KT; Lin MC; Tseng LH; Ogawa H
    Histopathology; 2015 Oct; 67(4):474-82. PubMed ID: 25648330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should endometrial clear cell carcinoma be classified as Type II endometrial carcinoma?
    Bae HS; Kim H; Young Kwon S; Kim KR; Song JY; Kim I
    Int J Gynecol Pathol; 2015 Jan; 34(1):74-84. PubMed ID: 25473756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.